메뉴 건너뛰기




Volumn 10, Issue 5, 2014, Pages 1331-1333

The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries

Author keywords

CAPITA; Conjugate vaccine; Pneumococcus; Pneumonia; Vaccine

Indexed keywords

PLACEBO; PNEUMOCOCCUS VACCINE; HAEMOPHILUS VACCINE; POLYRIBITOL PHOSPHATE; POLYSACCHARIDE; PREVENAR13; VACCINE;

EID: 84901461973     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29031     Document Type: Note
Times cited : (3)

References (21)
  • 1
    • 0026655022 scopus 로고
    • Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: Possible implications for optimal use
    • PMID:1588149
    • Black SB, Shinefield HR, Fireman B, Hiatt R. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis 1992; 165(Suppl 1):S139-43; PMID:1588149; http://dx.doi.org/10.1093/ infdis/165-Supplement-1-S139
    • (1992) J Infect Dis , vol.165 , Issue.SUPPL. 1
    • Black, S.B.1    Shinefield, H.R.2    Fireman, B.3    Hiatt, R.4
  • 2
    • 0034063425 scopus 로고    scopus 로고
    • Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
    • Northern California Kaiser Permanente Vaccine Study Center Group. PMID:10749457
    • Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al.; Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95; PMID:10749457; http://dx.doi.org/10.1097/00006454-200003000-00003
    • (2000) Pediatr Infect Dis J , vol.19 , pp. 187-195
    • Black, S.1    Shinefield, H.2    Fireman, B.3    Lewis, E.4    Ray, P.5    Hansen, J.R.6    Elvin, L.7    Ensor, K.M.8    Hackell, J.9    Siber, G.10
  • 3
    • 71949103062 scopus 로고    scopus 로고
    • Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
    • Active Bacterial Core Surveillance/Emerging Infections Program Network. PMID:19947881
    • Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, et al.; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41; PMID:19947881; http://dx.doi.org/10.1086/648593
    • (2010) J Infect Dis , vol.201 , pp. 32-41
    • Pilishvili, T.1    Lexau, C.2    Farley, M.M.3    Hadler, J.4    Harrison, L.H.5    Bennett, N.M.6    Reingold, A.7    Thomas, A.8    Schaffner, W.9    Craig, A.S.10
  • 4
    • 84884637235 scopus 로고    scopus 로고
    • Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: A pooled analysis of multiple surveillance sites
    • Serotype Replacement Study Group. PMID:24086113
    • Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10:e1001517; PMID:24086113; http://dx.doi.org/10.1371/ journal.pmed.1001517
    • (2013) PLoS Med , vol.10
    • Feikin, D.R.1    Kagucia, E.W.2    Loo, J.D.3    Link-Gelles, R.4    Puhan, M.A.5    Cherian, T.6    Levine, O.S.7    Whitney, C.G.8    O'Brien, K.L.9    Moore, M.R.10
  • 5
    • 79951849231 scopus 로고    scopus 로고
    • The potential role for protein-conjugate pneumococcal vaccine in adults: What is the supporting evidence?
    • PMID:21292668
    • Musher DM, Sampath R, Rodriguez-Barradas MC. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence? Clin Infect Dis 2011; 52:633-40; PMID:21292668; http://dx.doi.org/10. 1093/cid/ciq207
    • (2011) Clin Infect Dis , vol.52 , pp. 633-640
    • Musher, D.M.1    Sampath, R.2    Rodriguez-Barradas, M.C.3
  • 8
    • 58849088139 scopus 로고    scopus 로고
    • Efficacy of pneumococcal vaccination in adults: A meta-analysis
    • PMID:19124790
    • Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180:48-58; PMID:19124790; http://dx.doi.org/10.1503/cmaj.080734
    • (2009) CMAJ , vol.180 , pp. 48-58
    • Huss, A.1    Scott, P.2    Stuck, A.E.3    Trotter, C.4    Egger, M.5
  • 9
    • 84901406293 scopus 로고    scopus 로고
    • Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 Years of follow-up in the CAPAMIS study
    • PMID:24532544
    • Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis 2014; 58:909-17; PMID:24532544; http://dx.doi.org/10.1093/cid/ciu002
    • (2014) Clin Infect Dis , vol.58 , pp. 909-917
    • Ochoa-Gondar, O.1    Vila-Corcoles, A.2    Rodriguez-Blanco, T.3    Gomez-Bertomeu, F.4    Figuerola-Massana, E.5    Raga-Luria, X.6    Hospital-Guardiola, I.7
  • 10
    • 84868018443 scopus 로고    scopus 로고
    • Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention (CDC). PMID:23051612
    • Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816-9; PMID:23051612
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , pp. 816-819
  • 11
    • 52449104895 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients
    • PMID:18715160
    • Kumar D, Chen MH, Wong G, Cobos I, Welsh B, Siegal D, Humar A. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis 2008; 47:885-92; PMID:18715160; http://dx.doi.org/10.1086/591537
    • (2008) Clin Infect Dis , vol.47 , pp. 885-892
    • Kumar, D.1    Chen, M.H.2    Wong, G.3    Cobos, I.4    Welsh, B.5    Siegal, D.6    Humar, A.7
  • 12
    • 84930479362 scopus 로고    scopus 로고
    • Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?
    • PMID:22848316
    • Ridda I, Musher DM. Is there a potential role for protein-conjugate pneumococcal vaccine in older adults? Australas Med J 2012; 5:231-5; PMID:22848316; http://dx.doi.org/10.4066/AMJ.2012.1160
    • (2012) Australas Med J , vol.5 , pp. 231-235
    • Ridda, I.1    Musher, D.M.2
  • 13
    • 0034679239 scopus 로고    scopus 로고
    • 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: Double-blind, randomised and placebo controlled trial
    • PMID:10902624
    • French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355:2106-11; PMID:10902624; http://dx.doi.org/10. 1016/S0140-6736(00)02377-1
    • (2000) Lancet , vol.355 , pp. 2106-2111
    • French, N.1    Nakiyingi, J.2    Carpenter, L.M.3    Lugada, E.4    Watera, C.5    Moi, K.6    Moore, M.7    Antvelink, D.8    Mulder, D.9    Janoff, E.N.10
  • 15
    • 40449104823 scopus 로고    scopus 로고
    • A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients
    • PMID:18190318
    • Kumar D, Chen MH, Welsh B, Siegal D, Cobos I, Messner HA, Lipton J, Humar A. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 2007; 45:1576-82; PMID:18190318; http://dx.doi.org/10.1086/523583
    • (2007) Clin Infect Dis , vol.45 , pp. 1576-1582
    • Kumar, D.1    Chen, M.H.2    Welsh, B.3    Siegal, D.4    Cobos, I.5    Messner, H.A.6    Lipton, J.7    Humar, A.8
  • 16
    • 33847701746 scopus 로고    scopus 로고
    • Immunogenicity of pneumococcal vaccine in renal transplant recipients - Three year follow-up of a randomized trial
    • PMID:17217436
    • Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients - three year follow-up of a randomized trial. Am J Transplant 2007; 7:633-8; PMID:17217436; http://dx.doi.org/10.1111/j.1600-6143.2007.01668.x
    • (2007) Am J Transplant , vol.7 , pp. 633-638
    • Kumar, D.1    Welsh, B.2    Siegal, D.3    Chen, M.H.4    Humar, A.5
  • 17
    • 84889084599 scopus 로고    scopus 로고
    • Pneumococcal vaccine responses in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance
    • Karlsson J, Hogevik H, Anderssson K, Roshani L, Andreasson B, Wenneras C. Pneumococcal vaccine responses in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance. Trials Vaccinol 2013; 2:31-8; http://dx.doi.org/10.1016/j.trivac. 2013.09.001
    • (2013) Trials Vaccinol , vol.2 , pp. 31-38
    • Karlsson, J.1    Hogevik, H.2    Anderssson, K.3    Roshani, L.4    Andreasson, B.5    Wenneras, C.6
  • 18
    • 84901468713 scopus 로고    scopus 로고
    • Community-acquired pneumonia
    • In press
    • Musher DM, Thorner AL. Community-acquired pneumonia. N Engl J Med 2014; 372: In press.
    • (2014) N Engl J Med , vol.372
    • Musher, D.M.1    Thorner, A.L.2
  • 19
    • 40549104180 scopus 로고    scopus 로고
    • A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU
    • PMID:17989157
    • Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008; 133:610-7; PMID:17989157; http://dx.doi.org/10.1378/chest.07-1456
    • (2008) Chest , vol.133 , pp. 610-617
    • Restrepo, M.I.1    Mortensen, E.M.2    Velez, J.A.3    Frei, C.4    Anzueto, A.5
  • 20
    • 78649873377 scopus 로고    scopus 로고
    • Integrated analysis of FOCUS 1 and FOCUS 2: Randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia
    • PMID:21067350
    • File TM Jr., Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010; 51:1395-405; PMID:21067350; http://dx.doi.org/10.1086/657313
    • (2010) Clin Infect Dis , vol.51 , pp. 1395-1405
    • File Jr., T.M.1    Low, D.E.2    Eckburg, P.B.3    Talbot, G.H.4    Friedland, H.D.5    Lee, J.6    Llorens, L.7    Critchley, I.8    Thye, D.9
  • 21
    • 84878357078 scopus 로고    scopus 로고
    • Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study
    • PMID:23523447
    • Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013; 67:11-8; PMID:23523447; http://dx.doi.org/10.1016/j.jinf.2013.03.003
    • (2013) J Infect , vol.67 , pp. 11-18
    • Musher, D.M.1    Roig, I.L.2    Cazares, G.3    Stager, C.E.4    Logan, N.5    Safar, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.